Jul 30, 2020 / 12:00PM GMT
Operator
Good morning and welcome to Agios' Second Quarter 2020 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at Agios' request.
I would now like to turn the call over to Holly Manning, Director of Investor Relations.
Holly Manning - Agios Pharmaceuticals, Inc. - Associate Director of IR
Thank you, operator. Good morning, everyone, and welcome to Agios' Second Quarter 2020 Conference Call. You can access slides for today's call by going to the Investors section of our website, agios.com.
With me on the call today with prepared remarks are Dr. Jackie Fouse, our Chief Executive Officer; Dr. Chris Bowden, our Chief Medical Officer; Darrin Miles, our Senior Vice President of U.S. Commercial and Global Marketing; and Andrew Hirsch, our Chief Financial Officer and Head of Corporate Development. Dr. Bruce Car, our Chief Scientific Officer, will join for Q&A.
Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements.
Q2 2020 Agios Pharmaceuticals Inc Earnings Call Transcript
Jul 30, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers